About
EditForce develops RNA editing technologies based on pentatricopeptide repeat (PPR) proteins and applies these tools to drug discovery, chemicals, and agriculture.
Explore EditForce's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.